Exploring Uptrends: $CI, $HUM, $MOH, $ELV, $OSCR Lead Managed Health Care’s +5.23% Gain!
As the Managed Health Care sector experiences a 5.23% gain, this analysis will spotlight on how specific tickers contributed to this uptrend over the last month. We’ll concentrate on $CI, $HUM, $MOH, $ELV, and $OSCR, diving into their performance and market behavior.
💼 Managed Health Care Sector: Elevate Your Trading Game with AI Robots! 💼
If you're keen on exploring the Managed Health Care group, we have the perfect tools to assist you in your trading journey. 🏥📈
🔄 "Swing Trader for Beginners: Trading in Markets Trending Down (TA&FA)" is designed to help you navigate markets in decline. Whether you're a seasoned trader or just starting, this AI robot can provide valuable insights and strategies to thrive in challenging conditions.
⬆️ On the flip side, "Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA)" is your go-to companion when markets are on the rise. It offers a tailored approach to capitalize on upward trends and maximize your trading potential.
With these AI-powered tools at your disposal, you can confidently trade within the Managed Health Care sector, adapting to different market conditions and making informed decisions. Elevate your trading game and embark on a journey of trading excellence! 📊🚀
Tickers in this Group:
$CI - $HUM - $UNH - $MOH - $CNC - $CVS - $ELV - $OSCR - $ALHC
Description
Managed Health Care firms offer crucial health, medical, and disability plans aiming to streamline the cost of health care services. Major firms in this sector, including Aetna, Humana Inc., Cigna, UnitedHealthcare, provide insurance through various channels, ultimately aiming to make health care more accessible and affordable to the public.
Market Cap Analysis
With a group average market capitalization of $96.3B, the sector presents a diverse range of companies from $UNH at the pinnacle with $473B to $OSCR at $1.2B. This vast difference outlines the sector's diversity, offering traders various options to invest based on their market cap preference.
High and Low Price Notable News
The sector observed an average weekly growth of 0.45%, with a monthly enhancement of 5.77%. $ALHC leads the growth at 8%, while $ELV experienced a 1.53% decline. These fluctuations provide traders with insights into the tickers’ volatility and potential investment return.
Volume Insights
The sector’s stocks recorded an average weekly volume growth of -1.11%, with a significant decrease in the monthly and quarterly volume growth, which traders should consider when planning their investment strategies.
Fundamental Analysis Ratings
- Valuation Rating: 40
- P/E Growth Rating: 73
- Price Growth Rating: 43
- SMR Rating: 78
- Profit Risk Rating: 50
- Seasonality Score: 52
Ticker Spotlight: $CI, $HUM, $MOH, $ELV, $OSCR
$CI - Cigna Group (The)
$CI has shown a promising upward trend with its 10-day moving average crossing above its 50-day counterpart, signaling a potential buying opportunity with an 86% chance of continued growth.
$HUM - Humana
With its price surging above the 50-day moving average, $HUM indicates a strong upward trend, providing traders an 80% likelihood of further price increase in the upcoming month.
$MOH - Molina Healthcare
$MOH broke its lower Bollinger Band, suggesting a potential rise back towards the middle band. With an 81% chance of upward movement, this ticker presents a promising buy for traders.
$ELV - Elevance Health
$ELV is expected to rebound from its lower Bollinger Band, offering traders a probable 78% chance of engaging in a continued uptrend in the next month.
$OSCR - Oscar Health
Breaking its lower Bollinger Band, $OSCR provides traders with a compelling buy option, boasting an 83% probability of sustaining its upward trend.
With the Managed Health Care sector experiencing a +5.23% gain, tickers like $CI, $HUM, $MOH, $ELV, and $OSCR are at the forefront of this positive movement. As traders, understanding the nuances of each ticker’s performance, market cap, and volume growth is crucial for making informed investment decisions in this thriving sector.
CI saw its Stochastic Oscillator peaks and leaves the overbought zone
The Stochastic Oscillator for CI moved out of overbought territory on June 17, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 63 similar instances where the indicator exited the overbought zone. In of the 63 cases the stock moved lower. This puts the odds of a downward move at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day moving average for CI crossed bearishly below the 50-day moving average on May 15, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CI broke above its upper Bollinger Band on June 13, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CI's RSI Indicator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 11, 2025. You may want to consider a long position or call options on CI as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CI just turned positive on June 09, 2025. Looking at past instances where CI's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CI advanced for three days, in of 347 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.234) is normal, around the industry mean (3.063). P/E Ratio (20.936) is within average values for comparable stocks, (17.509). Projected Growth (PEG Ratio) (0.928) is also within normal values, averaging (1.089). Dividend Yield (0.014) settles around the average of (0.020) among similar stocks. P/S Ratio (0.554) is also within normal values, averaging (0.684).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of life, hospital and medical insurance plans
Industry ManagedHealthCare